Literature DB >> 18056713

An investigation of the ligand binding properties and negative cooperativity of soluble insulin-like growth factor receptors.

Katharina Helen Surinya1, Briony E Forbes, Filomena Occhiodoro, Grant W Booker, Geoffrey Leonard Francis, Kenneth Siddle, John C Wallace, Leah J Cosgrove.   

Abstract

To investigate the interaction of the insulin-like growth factor (IGF) ligands with the insulin-like growth factor type 1 receptor (IGF-1R), we have generated two soluble variants of the IGF-1R. We have recombinantly expressed the ectodomain of IGF-1R or fused this domain to the constant domain from the Fc fragment of mouse immunoglobulin. The ligand binding properties of these soluble IGF-1Rs for IGF-I and IGF-II were investigated using conventional ligand competition assays and BIAcore biosensor technology. In ligand competition assays, the soluble IGF-1Rs both bound IGF-I with similar affinities and a 5-fold lower affinity than that seen for the wild type receptor. In addition, both soluble receptors bound IGF-II with similar affinities to the wild type receptor. BIAcore analyses showed that both soluble IGF-1Rs exhibited similar ligand-specific association and dissociation rates for IGF-I and for IGF-II. The soluble IGF-1R proteins both exhibited negative cooperativity for IGF-I, IGF-II, and the 24-60 antibody, which binds to the IGF-1R cysteine-rich domain. We conclude that the addition of the self-associating Fc domain to the IGF-1R ectodomain does not affect ligand binding affinity, which is in contrast to the soluble ectodomain of the IR. This study highlights some significant differences in ligand binding modes between the IGF-1R and the insulin receptor, which may ultimately contribute to the different biological activities conferred by the two receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056713     DOI: 10.1074/jbc.M707054200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  t-Darpp Activates IGF-1R Signaling to Regulate Glucose Metabolism in Trastuzumab-Resistant Breast Cancer Cells.

Authors:  Gal Lenz; Angelica Hamilton; Shuhui Geng; Teresa Hong; Markus Kalkum; Jamil Momand; Susan E Kane; Janice M Huss
Journal:  Clin Cancer Res       Date:  2017-11-27       Impact factor: 12.531

2.  Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor.

Authors:  Nicholas J Bessman; Atrish Bagchi; Kathryn M Ferguson; Mark A Lemmon
Journal:  Cell Rep       Date:  2014-11-06       Impact factor: 9.423

3.  Aspartate 458 of human glutathione synthetase is important for cooperativity and active site structure.

Authors:  Teresa R Brown; Michael L Drummond; Sarah Barelier; Amanda S Crutchfield; Adriana Dinescu; Kerri D Slavens; Thomas R Cundari; Mary E Anderson
Journal:  Biochem Biophys Res Commun       Date:  2011-07-12       Impact factor: 3.575

4.  Alanine scanning of a putative receptor binding surface of insulin-like growth factor-I.

Authors:  Lisbeth Gauguin; Carlie Delaine; Clair L Alvino; Kerrie A McNeil; John C Wallace; Briony E Forbes; Pierre De Meyts
Journal:  J Biol Chem       Date:  2008-05-23       Impact factor: 5.157

5.  Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonist.

Authors:  Susana Frago; Ryan D Nicholls; Madeleine Strickland; Jennifer Hughes; Christopher Williams; Lee Garner; Mirvat Surakhy; Rory Maclean; Dellel Rezgui; Stuart N Prince; Oliver J Zaccheo; Daniel Ebner; Sabina Sanegre; Sheng Yu; Francesca M Buffa; Matthew P Crump; Andrew Bassim Hassan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-02       Impact factor: 11.205

6.  [99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours.

Authors:  Anna Orlova; Camilla Hofström; Joanna Strand; Zohreh Varasteh; Mattias Sandstrom; Karl Andersson; Vladimir Tolmachev; Torbjörn Gräslund
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-21       Impact factor: 9.236

7.  A Loss of Epigenetic Control Can Promote Cell Death through Reversing the Balance of Pathways in a Signaling Network.

Authors:  Kiran G Vanaja; Winston Timp; Andrew P Feinberg; Andre Levchenko
Journal:  Mol Cell       Date:  2018-09-20       Impact factor: 17.970

8.  Understanding the mechanism of insulin and insulin-like growth factor (IGF) receptor activation by IGF-II.

Authors:  Clair L Alvino; Shee Chee Ong; Kerrie A McNeil; Carlie Delaine; Grant W Booker; John C Wallace; Briony E Forbes
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

Review 9.  Theoretical and computational studies of peptides and receptors of the insulin family.

Authors:  Harish Vashisth
Journal:  Membranes (Basel)       Date:  2015-02-11

Review 10.  Roles of insulin-like growth factor II in regulating female reproductive physiology.

Authors:  Tahir Muhammad; Mengjing Li; Jianfeng Wang; Tao Huang; Shigang Zhao; Han Zhao; Hongbin Liu; Zi-Jiang Chen
Journal:  Sci China Life Sci       Date:  2020-04-10       Impact factor: 6.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.